Hans Ludger Tillmann. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antiviral Agents/administration & dosageFemaleHepacivirus/classificationHepatitis C/drug therapyHumansInterferon alpha-2Interferon-alpha/administration & dosageLiver Cirrhosis/virologyMalePolyethylene Glycols/administration & dosageProline/administration & dosageProline/analogs & derivativesRecombinant Proteins/administration & dosageRibavirin/administration & dosage
Substances： See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinN-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamideProlinepeginterferon alfa-2b
Year: 2012 PMID： 23247067 DOI： 10.1016/j.jhep.2012.12.007
Source DB: PubMed Journal: J Hepatol ISSN： 0168-8278 Impact factor: 25.083